Lupin introduces generic Rapaflo
Lupin has launched silodosin capsules, its generic of Allergan's Rapaflo. The generic Rapaflo will be available in 4- and 8-mg dosage strengths, having received the Food and Drug Administration's clearance earlier.
The generic Rapaflo which is an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia.
The product had annual sales of $198.5 million, according to September 2018 IQVIA data.
The generic Rapaflo which is an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia.
The product had annual sales of $198.5 million, according to September 2018 IQVIA data.